Therefore, in this study, we determined the in vitro efficacy of cariprazine to reverse resistance to the anticancer drug, mitoxantrone, an ABCG2 substrate, mediated by the overexpression of ABCG2 transporters in non-small lung cancer cells and colon cancer cells. This evidence concerns the gene ABCG2 and colonic neoplasm.